The pervasiveness of interleukin-1 in alzheimer pathogenesis: a role for specific polymorphisms in disease risk.
about
New obesity classification criteria as a tool for bariatric surgery indicationBioenergetic dysfunction and inflammation in Alzheimer's disease: a possible connectionInterleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathwayPotential therapeutic uses of interleukin 1 receptor antagonists in human diseases.Pharmacogenomics for the treatment of dementia.Osteoarthritis accelerates and exacerbates Alzheimer's disease pathology in mice.Tryptophan, Neurodegeneration and HIV-Associated Neurocognitive Disorder.Inhibition of Src kinase activity attenuates amyloid associated microgliosis in a murine model of Alzheimer's disease.Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray studyDifferential regulation of inhibitors of apoptosis proteins in Alzheimer's disease brainsThe role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective.Interleukin-1 promotion of MAPK-p38 overexpression in experimental animals and in Alzheimer's disease: potential significance for tau protein phosphorylation.Sustained expression of interleukin-1beta in mouse hippocampus impairs spatial memoryCaspase-6 as a novel early target in the treatment of Alzheimer's disease.Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context.The inflammasome and IL-1β: implications for the treatment of inflammatory diseases.Vitamin E suppression of microglial activation is neuroprotectiveActivation of microglia and induction of pro-inflammatory cytokines in the hippocampus of type 2 diabetic rats.MicroRNAs can regulate human APP levels.Triflusal reduces dense-core plaque load, associated axonal alterations and inflammatory changes, and rescues cognition in a transgenic mouse model of Alzheimer's disease.PTU-induced hypothyroidism in rats leads to several early neuropathological signs of Alzheimer's disease in the hippocampus and spatial memory impairments.Regulated intramembrane proteolysis of the interleukin-1 receptor II by alpha-, beta-, and gamma-secretase.Cyclooxygenase-2 and presenilin-1 gene expression induced by interleukin-1beta and amyloid beta 42 peptide is potentiated by hypoxia in primary human neural cells.The role of NLRP3-CASP1 in inflammasome-mediated neuroinflammation and autophagy dysfunction in manganese-induced, hippocampal-dependent impairment of learning and memory ability.
P2860
Q26774656-97EE191C-AB50-4B82-B284-61C0527FB6DFQ26822410-CA4AAAA9-3059-4466-9E7F-FCC1574E618DQ28571359-BF916599-4DAE-4253-83C9-438022856B54Q30863549-6948B01A-F438-41EA-A7AF-DBF71F257582Q35009345-20E91AA0-3ACD-4834-8259-BA2FFFB1F02AQ35231254-5B95120B-C426-4ECD-B8CD-6C7BB81750E6Q35366778-BCDAA2B3-5530-418A-98D0-C528A5C72221Q36071481-AAAEACAA-8B30-429B-A4BB-A72787BC613EQ36164195-0AC1D231-C975-47CE-8FD3-58582716E66EQ36380210-4D89F806-360F-4BE7-B27E-D8F0E23E85B3Q37095615-65FF6DF3-5258-4431-AA8C-AFFD20B8F0F8Q37324225-DABE6EF4-2727-4218-BF7D-F71205727382Q37438023-9ECCC6CB-E63F-4831-804F-1420CF3B79C8Q38114942-80446867-55E0-4AAC-8BC5-749EF44B2878Q38316988-3F23D7AF-124F-4AF0-8F7C-209A3333B4ECQ38389302-7049163A-14FB-407A-B040-78B0790CDBC9Q40776019-856656F5-5B4D-47CC-8D56-D964508F17ACQ42226999-52EA0C87-1DA9-494B-9D94-CCC37CE06F41Q42426890-63810E13-103B-42FB-AA99-0E46F599FA34Q43098773-9181EAC5-B767-423E-B161-F1B8E8670C79Q44900063-6A84DF10-5E6A-49EA-B6E1-9271AE928ACDQ48269632-51EA2CB1-8ADF-4714-9220-9531B5F2E9AEQ48587234-52CF311A-B596-461C-BD60-00E362541135Q50450076-712A7834-F82B-4471-A06F-A6353C618C45
P2860
The pervasiveness of interleukin-1 in alzheimer pathogenesis: a role for specific polymorphisms in disease risk.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
The pervasiveness of interleuk ...... polymorphisms in disease risk.
@ast
The pervasiveness of interleuk ...... polymorphisms in disease risk.
@en
The pervasiveness of interleuk ...... polymorphisms in disease risk.
@nl
type
label
The pervasiveness of interleuk ...... polymorphisms in disease risk.
@ast
The pervasiveness of interleuk ...... polymorphisms in disease risk.
@en
The pervasiveness of interleuk ...... polymorphisms in disease risk.
@nl
prefLabel
The pervasiveness of interleuk ...... polymorphisms in disease risk.
@ast
The pervasiveness of interleuk ...... polymorphisms in disease risk.
@en
The pervasiveness of interleuk ...... polymorphisms in disease risk.
@nl
P2093
P2860
P921
P1476
The pervasiveness of interleuk ...... polymorphisms in disease risk.
@en
P2093
J A Nicoll
L M Grimaldi
W S Griffin
P2860
P304
P356
10.1016/S0531-5565(00)00110-8
P577
2000-07-01T00:00:00Z